Publication | Closed Access

Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence

Tumor BiologyBreast OncologyMedicineLow RiskPathologyBreast CancerCancer BiologyTumor CytosolsOncologyCell BiologyLow Cathepsin DCancer ResearchCancer Growth